Pablo Rendo Selected Research

recombinant factor VIII SQ

9/2020	Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia A.
1/2020	Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies.
1/2018	Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF-CC) in Subjects With Severe Hemophilia A.
10/2015	Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Rendo Research Topics

Disease

7	Hemorrhage 05/2021 - 10/2013
5	Hemophilia B (Haemophilia B) 05/2021 - 12/2015
5	Hemophilia A (Haemophilia) 09/2020 - 10/2013
1	Body Weight (Weight, Body) 10/2013
1	Joint Diseases (Joint Disease) 10/2013
1	Inflammation (Inflammations) 10/2013
1	Infections 01/2002
1	Anemia 01/2002
1	Neoplasms (Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

6	Factor IX (Coagulation Factor IX)FDA LinkGeneric 05/2021 - 10/2013
4	recombinant factor VIII SQIBA 09/2020 - 10/2015
4	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 10/2013
3	AlbuminsIBA 01/2020 - 10/2015
2	Therapeutic UsesIBA 10/2015 - 01/2002
1	fibrin fragment D (D-dimer)IBA 01/2018
1	prothrombin complex concentrates (PPSB)IBA 01/2018
1	antithrombin III-protease complexIBA 01/2018
1	Prothrombin (Factor II)IBA 01/2018
1	Hemostatics (Antihemorrhagics)IBA 10/2013
1	Alanine Transaminase (SGPT)IBA 01/2002
1	Erythropoietin FDA Link 01/2002

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2018
1	Renal Dialysis (Hemodialysis) 01/2002